L. Casali (Terni, Italy), J-P. Janssens (Geneva, Switzerland)
Tolerance to rifampicine (RIF) 4 months vs. isoniazid (INH) 6 months for latent tuberculosis infection (LTBI)
I. Fresard, E. Langenskiold, P. O. Bridevaux, T. Rochat, J. P. Janssens (Geneva, Lausanne, Switzerland)
|   |
Students-risk group in a high TB endemic country
V. Cojocariu, A. Sorete Arbore, R. Sorete Arbore (Iasi, Romania)
| |
Clinico-radiological profile of tuberculosis in HIV seropositive patients of western Rajasthan
N. Jain, P. Gupta, K. K. Sharma, R. Jenaw, Y. Tak (Jaipur, India)
| |
The effect of immunosuppressives on the tuberculin skin test
S. F. Zuhur, I. Ozdemir, B. Müsellim, S. Erturan, G. Hatemi, V. Hamuryudan, G. Ongen (Istanbul, Turkey)
| |
Consideration about the results of chemotherapy at relapsed cases with pulmonary TB in Dolj County, Romania, 2001-2005
M. Popescu-Hagen, M. Tanasescu, D. Bica, B. Mahler, M. Nitu, C. Didilescu, C. Marica (Bucharest, Craiova, Romania)
| |
Tuberculosis in the province of Siena and a project of health education for immigrants
S. Gianni, P. M. Olia (Siena, Italy)
| |
Completeness of notification of adult tuberculosis in Iasi County, Romania: a capture-recapture analysis
C. Cojocaru, R. Van Hest, T. Mihaescu, P. Davies (Iasi, Romania; Rotterdam, Netherlands; Liverpool, United Kingdom)
| |
Tobacco smoking may increase the disease transmission of pulmonary tuberculosis
T. Nagao, K. Doi, M. Ito, C. Nishio, T. Hajiro, Y. Nakano (Shiga, Osaka, Japan)
| |
Results of active case finding among Roma minority group in Kosovo, 2007
X. Kurhasani, R. Mehmeti, B. Beqiri, B. Tigani, L. Adams (Prishtina, Kosovo, Peja, Kosovo, Albania; Hanover, NH, United States Of America)
| |
Factors associated with death among tuberculosis patients in Taipei
C. Y. Chiang, J. J. Lee, M. C. Yu, D. Enarson, T. P. Lin, K. T. Luh (Paris, France; Hualien, Taipei, Taiwan, Province Of China)
| |
Correlation of CD4 counts with pulmonary and extrapulmonary tuberculosis in AIDS: an Indian study
D. Bhattacharyya, B. N. B. M. Prasad, A. D. Mathur (Delhi Cantt/Delhi, India)
| |
Drug resistance of mycobacterium tuberculosis isolates in Serbia over five-year period (2001-2005)
B. Savic, D. Vukovic, G. Stefanovic, I. Dakic, L. Tomic (Belgrade, Serbia And Montenegro)
| |
The treatment results in previously treated patients with standard category 2 regimen
S. Cherenko, L. Tsygankova, N. Litvinenko, J. Senko, E. Tarasenko, I. Slutch (Kiev, Ukraine)
| |
The prevalence of drug resistance tuberculosis in previously treated patients
S. Cherenko, V. Penrenko, Y. Volskiy, L. Tsygankova, J. Senko, N. Litvinenko, A. Ghurilo, A. Barbova (Kiev, Ukraine)
| |
Prevalence of MDR TB and XDR TB in a tertiary care hospital in India
M. Kale, P. Khatavkar, U. Salunkhe, V. Patil, M. Satpute, N. Telang (Pune, Maharashtra, India)
| |
Treatment outcome of XDR-TB patients in Iran during 2003-2006
P. Tabarsi, P. Baghaei, E. Chitsaz, P. Farnia, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Treatment outcome of tuberculosis in Sohag governorate: directly observed therapy compared with self-administered therapy
H. Mahmmoud, E. Abdel Baset (Sohag, Egypt)
| |
Directly observed therapy (DOT) at Izmir Esrefpasa Tuberculosis Dispensary during the process of health sector reform in Turkey
S. Alptekin, M. Aydin, S. Arslangiray (Izmir, Turkey)
| |
Intensive detection of tuberculosis in institutionalized persons
C. Didilescu, M. Tigau, I. Dediu, I. Stoicescu (Bucharest, Romania)
| |
Evolution of the main indicators of the TB endemic 7 years after applying DOTS in the 4th sector of Bucharest
C. Didilescu, D. I. Chiotan, E. Ibraim, D. Lugoji, I. Dediu, M. Tigau, C. Teoibas, M. Popescu, R. Spataru, T. Palaghianu, C. Marica, N. Galie (Bucharest, Romania)
| |